Mashpee, MA, United States of America

Chris J Viau

This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignee: Aileron Therapeutics, Inc.. Active years: 2019.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Chris J Viau: Innovator in Cancer Treatment

Introduction

Chris J Viau is a notable inventor based in Mashpee, MA (US). He has made significant contributions to the field of cancer treatment through his innovative work. With a total of two patents to his name, Viau is recognized for his advancements in medical technology.

Latest Patents

Viau's latest patents focus on peptidomimetic macrocycles and their applications in treating various types of cancer. One patent details methods for treating solid tumors that lack a p53 deactivation mutation. This patent also includes peptidomimetic macrocycles designed for use in such treatments. Another patent addresses methods for treating liquid cancers, again targeting those determined to lack a p53 deactivation mutation. These innovations represent a significant step forward in cancer therapy.

Career Highlights

Chris J Viau is currently associated with Aileron Therapeutics, Inc., where he continues to develop groundbreaking treatments. His work is pivotal in the ongoing fight against cancer, particularly in cases where traditional therapies may fall short.

Collaborations

Viau collaborates with esteemed colleagues such as Hubert Chen and David Allen Annis. Their combined expertise enhances the research and development efforts at Aileron Therapeutics, Inc.

Conclusion

Chris J Viau is a prominent figure in the realm of cancer treatment innovations. His patents and ongoing work at Aileron Therapeutics, Inc. highlight his commitment to improving patient outcomes. Through his contributions, Viau is making a lasting impact on the medical field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…